To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.

United States118th CongressHR-1393House of Representatives
Updated: Mar 17, 2023

Summary

This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-689: A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.

Read twice and referred to the Committee on the Judiciary.

  1. Introduced in House

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.